-
Latest News
- Development of a conceptual framework to underpin a health-related quality of life outcome measure in paediatric CFS/ME: prioritisation through card ranking
- CMRC conference (March) – tickets & programme available
- Changes in circulating microRNA after recumbent isometric yoga practice by patients with ME/CFS
- ME & CFS – no longer classified as ‘Bodily Distress Disorder’ (BDD)
- The impact of a Structured Exercise Programme upon cognitive function in CFS patients
Archives
Tag Archives: pharmacogenomics
Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
Treatment avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a split-gender pharmacogenomic study of gene-expression modules, by Mary G Jeffrey, Lubov Nathanson, Kristina Aenlle, Zachary M Barnes, Mirza Baig, Gordon Broderick, Nancy G Klimas, Mary Ann Fletcher, Travis JA Craddock in Clinical … Continue reading →
Posted in News
|
Tagged bioinformatics, Dr Nancy Klimas, drug repositioning, Gordon Broderick, immune dysregulation, immunosuppressants, Kistina Aenlle, Lubov Nathanson, Mary Ann Fletcher, Mary G Jeffrey, Mirza Baig, pharmacogenomics, Travis JA Craddock, treatments, Zachary Barnes
|
Comments Off on Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
